03347 泰格醫藥
公司資料 - 損益表
杭州泰格醫藥科技股份有限公司 股票編號: 03347
HANGZHOU TIGERMED CONSULTING CO., LTD. 集團網址: http://www.tigermedgrp.com
2023/12 - 末期
人民幣(K¥)
變動 2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
2019/12
人民幣(K¥)
營業額 / 收益7,384,0394.214%7,085,4715,213,5383,192,2792,803,309
銷售成本(4,563,378)6.124%(4,300,027)(2,965,420)(1,688,946)(1,511,409)
毛利2,820,6611.264%2,785,4442,248,1181,503,3331,291,900
 
投資物業公平值變動及減值------------
其他項目公平值變動及減值(68,098)177.103%(24,575)(24,426)10,075(21,186)
出售項目溢利 / (虧損)------------
其他非經營項目--------(3,567)--
分佔聯營公司及共同控制公司業績105,183164.525%39,76314,348(3,508)(9,768)
除稅前溢利 / (虧損)2,490,191-4.036%2,594,9123,689,5022,220,2621,088,772
稅項(338,606)7.956%(313,652)(292,864)(189,707)(113,839)
已終止經營業務溢利 / (虧損)------------
非控股權益(125,078)-52.832%(265,174)(517,539)(279,227)(133,686)
其他項目------------
股東應佔溢利 / (虧損)2,026,5070.517%2,016,0862,879,0991,751,328841,247
 
淨財務支出 / (收入)(110,927)-23.630%(145,249)(234,139)(63,317)15,409
折舊及攤銷339,02419.021%284,844196,762150,256104,202
董事酬金----7,8713,4873,3952,801
 
核數師意見無保留意見--無保留意見無保留意見無保留意見無保留意見
 
市場價值指標
每股盈利 (仙)234.000--233.000332.000220.000113.000
每股派息 (仙)56.800--55.00050.00030.000--
派息比率 (%)24.274%--23.605%15.060%13.636%--
每股現金流 ($)----1.3111.3431.1250.725
每股帳面資產淨值 ($)24.150--22.49920.84418.514--
 

Copyright © 2024 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.